ATM−/− mice mainly developed thymic lymphoma through an aberrant T cell receptor alpha/delta rearrangement and gene amplification (Zha et al., 2010), whereas AML is a clonal disease originated from stem cell and/or progenitor cell that often associated with genomic aberrations and chromosomal rearrangement. Here, ATM is linked to thymus lymphoma.